Can we finally fix growing drug shortages?
In a recent podcast episode, industry experts discuss why drug shortages are worsening. They explore how combining predictive analytics with flexible manufacturing could help make essential medicines more accessible.
Original image temporarily unavailable
Background
In this episode of the Denatured podcast, BioSpace Director of Insights Jennifer C. Smith-Parker talks with Antheia CEO Christina Smolke and Cencora data and AI product head Kyle Pudenz about the rising threat of drug shortages.
Details and Approach
The discussion examines the root causes behind worsening medicine shortages. The guests explore potential solutions, focusing on how predictive supply-chain analytics can anticipate disruptions and how agile, distributed manufacturing can make the production of essential medicines more resilient and accessible to patients.
View selection rationale
Importance 24/100
About this brief
- Content type
- Interview summary
- Source type
- Publisher report
- Original source
- BioSpace Drug Development ↗
- Source published
- Process
- AI-assisted discovery, translation, summarisation, classification and scoring; standards and corrections are maintained by the editorial desk.
- Verification
- The original URL and publication metadata are retained. This brief is not independently fact-checked unless explicitly stated.
- Published by
- Polyemergence Editorial Desk · PolyEmergence Pte Ltd.
- Conflict disclosure
- No financial or commercial conflict declared.